Stocks

CG Oncology CGON

Health care sectorNasdaq

What to see in CG Oncology now

Who bought more than 5%?9.7%

RTW Investments holds 9.7% · +1.4pp on the report before

Filed 08/14
Is Wall Street adding or cutting?−6

227 13F filers hold it · −6 against the quarter before · shares held +6.2%

Holdings of 06/30
Is stock about to come to market?$5.2M

$5.2M of planned sales filed in 30 days · 0.1% of the units outstanding

Filed 09/21

Company

Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Dallas, Texas
Fiscal year end
12/31
Next earnings
11/04, estimated
  • RTW Investments holds 9.7% · +1.4pp on the report beforeFiled 08/14
  • 227 13F filers hold it · −6 against the quarter before · shares held +6.2%Holdings of 06/30

Funds

13F filers: 227 · −6 since the quarter before · 06/30 holdings

Famous funds that held CG Oncology in their latest 13F report.

FundValueSince the quarter before
Mirae Asset Global ETFS HoldingsCG Oncology CGON · 06/30 holdings$3.2MNo quarter before
Mirae Asset Global InvestmentsCG Oncology CGON · 06/30 holdings$280.3KTrimmed −10.4%
All tracked funds

5% stakes

Holder
RTW Investments08/149.7%8,514,590 sh+1.4pp
Wellington Management Group08/136%5,324,751 sh−1.2pp
T. Rowe Price Investment Management05/158%6,720,389 shFirst report
RTW Investments05/158.3%6,984,808 shFirst report
Vanguard Group03/260%0 sh−8.6pp
Wellington Management Group25/11/127.2%5,512,779 shFirst report
Seven Fleet Capital Management25/10/282%1,542,833 shNo earlier report
Longitude Capital Partners IV25/09/186%4,662,268 shFirst report
Seven Fleet Partners25/09/182%1,515,151 shFirst report
FMR25/08/065.1%3,856,261 shFirst report
All 5% stake reports on CG Oncology

26-week trading